Target intelligence / Profile preview

Microvascular permeability and venous tone

Molecular classification
Physiological process, Clinical endpoint, Other
01

Overview

Microvascular permeability and venous tone refers to a set of physiological parameters and clinical endpoints rather than a single molecular target such as a receptor or enzyme (Source: PubMed, PMID: 15500339). Microvascular permeability is the capacity of the capillary and post-capillary venule walls to allow the passage of fluids, solutes, and cells, which is often pathologically increased in inflammatory states. Venous tone describes the degree of contraction of the smooth muscle within the venous wall, which is essential for maintaining venous return and preventing blood pooling in the lower extremities (Source: StatPearls, NBK557563). These processes are the primary focus of venoactive drugs, also known as phlebotonics, used to treat chronic venous insufficiency, varicose veins, and hemorrhoids. Drugs like diosmin and hesperidin modulate these parameters by prolonging the effect of noradrenaline on venous smooth muscle and inhibiting the release of inflammatory mediators like prostaglandins and leukotrienes (Source: PubMed, PMID: 11529667). Because this term encompasses broad physiological functions regulated by various receptors and enzymes, it does not represent a single, discrete therapeutic target molecule.

Other names
Capillary permeabilityVenous wall tensionVascular toneVenous capacitance
02

Mechanism of action

Venoactive drugs typically act by increasing the sensitivity of venous smooth muscle to noradrenaline, inhibiting the degradation of noradrenaline by catechol-O-methyltransferase (COMT), and reducing the activation and adhesion of leukocytes to the vascular endothelium, thereby decreasing the release of inflammatory mediators that increase permeability (Source: PubMed, PMID: 15500339; StatPearls, NBK557563).

03

Biological functions

Fluid homeostasisVascular resistanceInflammatory responseVenous returnOther
04

Disease associations

Chronic venous insufficiencyVaricose veinsLymphedemaHemorrhoidsDiabetic retinopathyCardiovascular diseaseOther
05

Safety considerations

Gastrointestinal disturbancesAutonomic nervous system symptoms (e.g., headache, insomnia)Potential for drug-drug interactions with anticoagulants
06

Interacting drugs

Diosmin

5 more in the full profile.

07

Biomarkers

Venous refill time (VRT)Capillary filtration rate (CFR)Transcutaneous oxygen tension (TcPO2)Ankle circumference

Beyond the preview

Go deeper on Microvascular permeability and venous tone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microvascular permeability and venous tone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call